That’s right I meant what I said in the title. I have been carping about the Medicare readmissions penalties since the program started and the research pretty much confirms how bad it is, including a recent analysis in the Journal of the American Medical Association, Internal Medicine. (JAMA Int. Med. Study) One of the conditions for which excessive readmissions are penalized is myocardial infarction or heart attack. The authors attempt to understand if there is a relationship between 30-day readmission performance and objective measures of care quality and long-term clinical outcomes. Over 176,000 patients at 380 hospitals. Smaller hospitals were generally excluded. CMS’ excess readmission rate was used for each of the hospitals. Standard process of care measure performance was evaluated via a pre-existing registry. Clinical outcomes included one-year all cause mortality or readmission. 43% of the hospitals had been deemed by CMS to have excessive readmissions. As other research has shown, there appeared to be demographic and health status factors that account for some of this performance, factors which CMS does not adjust for. In regard to most of the process of care measures, there was no difference in performance of hospitals across the readmission rate metric that CMS uses; i.e. there was no correlation. Following the initial 30-day period following discharge, there was no long-term risk association between the CMS readmission score and the clinical outcomes of mortality and readmission. Like all government bodies, CMS is stubborn as hell, believing in its own infallibility. It would be nice if it would dump or revise the program, but don’t expect it to recognize a mistake.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Now here is a tale from the glory days of epidemic investing, as the Feds pumped trillions into the economy and a lot of it went to investing, some to...
January 10, 2023
Another merger of two struggling “digital” health companies, which use virtual reality as a product design. Apparently you are less likely to drown in high seas when you are holding...
December 18, 2022
Mercer, a large benefits consulting firm, confirms that health plan premiums are rising in 2023, publishing survey results showing that employers expect an increase of costs by at least 5%....
December 9, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace